卵圆孔未闭与隐源性卒中的研究进展

摘要/Abstract

摘要：

经过全面筛查，仍有约40%找不到明确病因的缺血性卒中为隐源性卒中。卵圆孔未闭可引起反常栓塞，进而发生缺血性卒中。近年来发现，部分隐源性卒中可能由卵圆孔未闭导致。本文将从检查方法、作用、机制及治疗等方面对卵圆孔未闭与隐源性卒中的研究现状进行介绍。

文章导读： 本文从检查方法、作用、机制及治疗等方面对PFO与隐源性卒中的研究现状展开介绍，发现许多问题依然悬而未决，隐源性心房颤动和严重的软斑块的破裂，可能是引起CS的原因。

关键词: 卵圆孔未闭; 隐源性卒中; 超声; 治疗

Abstract:

Cryptogenic stroke is through a comprehensive screening, but still 40% of the stroke can not find a clear etiology. Patent foramen ovale may result in paradoxical embolism which will lead to stroke attack. In recent years, we found that some of the cryptogenic stroke may be cause by patent foramen ovale. This article will introduce the research status of inspection methods, mechanism and therapy of patent foramen ovale and cryptogenic stroke.

Key words: Patent foramen ovale; Cryptogenic stroke; Ultrasonic; Therapy

闫金红，李国忠. 卵圆孔未闭与隐源性卒中的研究进展[J]. 中国卒中杂志, 2015, 10(12): 1049-1053.

YAN Jin-Hong, LI Guo-Zhong. Research Progress in Patent Foramen Ovale and Cryptogenic Stroke[J]. Chinese Journal of Stroke, 2015, 10(12): 1049-1053.

参考文献

1 Finsterer J. Management of cryptogenic stroke[J].

Acta Neurol Belg, 2010, 110:135-147.

2 Hara H, Virmani R, Ladich E, et al. Patent foramen

ovale:current pathology, pathophysiology, and clinical

status[J]. J Am Coll Cardiol, 2005, 46:1768-1776.

3 Komar M, Podol e c P, P r zewlock i T, e t a1.

Transoesophageal echocardiography can help

distinguish between patients with “symptomatic” and

“asymptomatic” patent foramen ovale[J]. Kardiol Pol,

2012, 70:1258-1263.4 Rana BS, Shapi ro LM, McCar thy KP, e t a l .

Threedimensional imaging of the atrial septum

and patent foramen ovale anatomy:defining the

morphological phenotypes of patent foramen ovale[J].

Eur J Echocardiogr, 2010, 11:i19-25.

5 Tanaka J, Izumo M, Fukuoka Y, et al. Comparison of

two-dimensional versus real-time three-dimensional

transesophageal echocardiography for evaluation of

patent foramen ovale morphology[J]. Am J Cardiol,

2013, 111:1052-1056.

6 Cot t e r PE, Ma r t i n PJ, Bel ham M. Towa rd

understanding the atrial septum in cryptogenic

stroke[J]. Int J Stroke, 2011, 6:445-453.

7 Maffè S, Dellavesa P, Zenone F, et al. Transthoracic

second harmonic two-and th ree-dimensional

echocardiography for detection of patent foramen

ovale[J]. Eur J Echocardiogr, 2010, 11:57-63.

8 Hamilton-Craig C, Sestito A, Natale L, et al. Contrast

transoesophageal echocardiography remains superior

to contrast-enhanced cardiac magnetic resonance

imaging for the diagnosis of patent foramen ovale[J].

Eur J Echocardiogr, 2011, 12:222-227.

9 Kim YJ, Hur J, Shim CY, et al. Patent foramen

ovale:diagnosis with multidetector CT-comparison

with transesophageal echocardiography[J]. Radiology,

2009, 250:61-67.

10 Amarenco P, Bogousslavsky J, Caplan LR, et al.

Classification of stroke subtypes[J]. Cerebrovasc Dis,

2009, 27:493-501.

11 Amin H, Greer DM. Cryptogenic st roke-the

appropriate diagnostic evaluation[J]. Curr Treat

Options Cardiovasc Med, 2014, 16:280.

12 Frei l inger TM, Schindler A, Schmidt C, e t

al. Prevalence of nonst enosing, complicated

atherosclerotic plaques in cryptogenic stroke[J]. JACC

Cardiovasc Imaging, 2012, 5:397-405.

13 Johnson BI. Paradoxical embolism[J]. J Clin Pathol,

1951, 4:316-332.

14 Lippi G, Favaloro EJ, Franchini M. Paradoxical

thrombosis par t 1:factor replacement therapy,

inherited clotting factor deficiencies and prolonged

APTT[J]. J Thromb Thrombolysis, 2012, 34:360-366.

15 Sandler DA, Martin JF. Autopsy proven pulmonary

embolism in hospital patients:are we detecting enough

deep vein thrombosis?[J]. JR Soc Med, 1989, 82:203-205.

16 Cramer SC, Rordorf G, Maki JH, et al. Increased

pelvic vein thrombi in cryptogenic stroke:results of

the Paradoxical Emboli from Large Veins in Ischemic

Stroke (PELVIS) study[J]. Stroke, 2004, 35:46-50.

17 Palareti G, Schellong S. Isolated distal deep vein

thrombosis:what we know and what we are doing[J].J Thromb Haemost, 2012, 10:11-19.

18 Lehmeyer S, Lindhoff-Last E. New aspects of

paradoxical embolism[J]. Vasa, 2011, 40:31-40.

19 Spies C, Wong M. Patent foramen ovale and

cryptogenic stroke:a complex neuro-cardio-vascular

problem [J]. Expert Rev Cardiovasc Ther, 2009,

7:1455-1467.

20 Nendaz MR, Sarasin FP, Junod AF, et al. Preventing

stroke recurrence in patients with patent foramen

ovale:antithrombotic therapy, foramen closure,

or therapeutic abstention? A decision analytic

perspective[J]. Am Heart J, 1998, 135:532-541.

21 Mohr JP, Thompson JL, La za r RM et a l. A

comparison of warfarin and aspirin for the prevention

of recurrent ischemic stroke[J]. N Engl J Med, 2001,

345:1444-1451.

22 Shar iat A, Yaghoubi E, Farazdaghi M, et al.

Comparison of medical treatments in cryptogenic

st roke pat ients with patent foramen ovale:A

randomized clinical trial[J]. J Res Med Sci, 2013,

18:94-98.

23 Fischer D, Gardiwal A, Haentjes J, et al. Sustained risk

of recurrent thromboembolic events in patients with

patent foramen ovale and paradoxical embolism:longterm

follow-up over more than 15 years[J]. Clin Res

Cardiol, 2012, 101:297-303.

24 Ning M, Lo EH, Ning PC, et al. The brain's heartJ Thromb Haemost, 2012, 10:11-19.

18 Lehmeyer S, Lindhoff-Last E. New aspects of

paradoxical embolism[J]. Vasa, 2011, 40:31-40.

19 Spies C, Wong M. Patent foramen ovale and

cryptogenic stroke:a complex neuro-cardio-vascular

problem [J]. Expert Rev Cardiovasc Ther, 2009,

7:1455-1467.

20 Nendaz MR, Sarasin FP, Junod AF, et al. Preventing

stroke recurrence in patients with patent foramen

ovale:antithrombotic therapy, foramen closure,

or therapeutic abstention? A decision analytic

perspective[J]. Am Heart J, 1998, 135:532-541.

21 Mohr JP, Thompson JL, La za r RM et a l. A

comparison of warfarin and aspirin for the prevention

of recurrent ischemic stroke[J]. N Engl J Med, 2001,

345:1444-1451.

22 Shar iat A, Yaghoubi E, Farazdaghi M, et al.

Comparison of medical treatments in cryptogenic

st roke pat ients with patent foramen ovale:A

randomized clinical trial[J]. J Res Med Sci, 2013,

18:94-98.

23 Fischer D, Gardiwal A, Haentjes J, et al. Sustained risk

of recurrent thromboembolic events in patients with

patent foramen ovale and paradoxical embolism:longterm

follow-up over more than 15 years[J]. Clin Res

Cardiol, 2012, 101:297-303.

24 Ning M, Lo EH, Ning PC, et al. The brain's hearttherapeutic

oppor tunit ies for patent foramen

ovale(PFO) and neurovascular disease[J]. Pharmacol

Ther, 2013, 139:111-123.

25 Calvet D, Mas JL. Closure of patent foramen ovale in

cryptogenic stroke:a never ending story[J]. Curr Opin

Neurol, 2014, 27:13-19.

26 Thaler DE, Kent DM. Rethinking trial strategies for

stroke and patent foramen ovale[J]. Curr Opin Neurol,

2010, 23:73-78.

27 Furlan AJ, Reisman M, Massaro J, et al. Closure or

medical therapy for cryptogenic stroke with patent

foramen ovale[J]. N Engl J Med, 2012, 366:991-999.

28 Meier B, Kalesan B, Mattle HP, et al. Percutaneous

closure of patent foramen ovale in cryptogenic

embolism[J]. N Engl J Med, 2013, 368:1083-1091.

29 Carroll JD, Saver JL, Thaler DE, et al. Closure

of patent foramen ovale versus medical therapy

after cryptogenic stroke[J]. N Engl J Med, 2013,

368:1092-1100.

30 Windecker S, Meier B. Is closure recommended for

patent foramen ovale and cryptogenic stroke? patent

foramen ovale and cryptogenic stroke:to close or not

to close? Closure:what else![J]. Circulation, 2008,

118:1989-1998.

31 Sanna T, Diener HC, Passman RS, et al. Crytptogenic

stroke and underlying atrial fibrillation[J]. N Engl J

Med, 2014, 370:2478-2486.

[1]	曹黎明, 任力杰. 急性缺血性卒中诊疗技术的进展与展望[J]. 中国卒中杂志, 2024, 19(9): 983-989.
[2]	朱佳倩, 曹黎明. 卵圆孔未闭诊断方法与技术的研究进展[J]. 中国卒中杂志, 2024, 19(9): 991-997.
[3]	王静祎, 李华, 曹黎明. 经颅多普勒卧立位试验在脑血管病中的应用进展 [J]. 中国卒中杂志, 2024, 19(9): 998-1003.
[4]	符鹏程, 曹黎明, 朱佳倩, 赵桂玉, 徐格林. 大动脉粥样硬化性缺血性卒中再灌注治疗的研究进展[J]. 中国卒中杂志, 2024, 19(9): 1004-1011.
[5]	张丽苹, 曹黎明, 肖楠, 廖雨琦, 池枫, 余艳妮, 任力杰. 纳米材料在缺血性卒中诊疗中的研究进展及挑战[J]. 中国卒中杂志, 2024, 19(9): 1012-1017.
[6]	阿娜古丽·阿不拉尼压孜, 吴晓欣, 李骄星, 李竹浩, 盛文利. 急性缺血性卒中磁敏感血管征影响因素及临床应用的研究进展[J]. 中国卒中杂志, 2024, 19(9): 1077-1085.
[7]	田兵, 段建钢, 陈虹秀, 辜义鸿, 潘希娟, 邢英琦. 特发性高颅压临床特点和超声表现分析 [J]. 中国卒中杂志, 2024, 19(8): 895-901.
[8]	李光硕, 赵性泉. 《中国急性缺血性卒中诊治指南2023》解读[J]. 中国卒中杂志, 2024, 19(8): 956-961.
[9]	白磊鹏, 罗杰, 周思捷, 黄健辉, 梁铭钦, 赵庆顺. 肺叶楔形切除术后并发急性缺血性卒中行介入取栓治疗2例并文献回顾 [J]. 中国卒中杂志, 2024, 19(8): 962-966.
[10]	李丽君, 张宁, 陈琦, 王春雪. 主观性失眠与脑血管病慢性期功能预后的关系研究：基于多中心前瞻性研究的事后分析 [J]. 中国卒中杂志, 2024, 19(7): 815-821.
[11]	郭帅炜, 张亚南, 王硕. 血小板功能检测在神经外科止血功能评估中的现状与意义 [J]. 中国卒中杂志, 2024, 19(7): 848-853.
[12]	北京高血压防治协会, 中国卒中学会高血压预防与管理分会. 中国卒中患者高血压管理专家共识[J]. 中国卒中杂志, 2024, 19(6): 672-698.
[13]	李之明, 王孜杰, 李琦. 2024美国卒中学会Code ICH脑出血早期一体化诊治方案专家共识解读[J]. 中国卒中杂志, 2024, 19(6): 714-724.
[14]	刘玉梅, 杜利勇, 雷娜, 潘希娟, 邢英琦. 分层递进式教学在国家卒中血管超声示范中心培训中的应用[J]. 中国卒中杂志, 2024, 19(5): 592-596.
[15]	王伊龙. 脑小血管病的诊治现状及未来探索之路[J]. 中国卒中杂志, 2024, 19(4): 363-374.